Executive Summary
- •Neko Health and Neuralink are reportedly using body-scan data to pre-screen candidates for brain implant clinical trials.
- •Neko Health raised $700 million in Series C funding on July 15, 2026, ahead of opening its first US clinic on September 24, 2026.
- •The arrangement remains unconfirmed by official corporate channels after surfacing on social media.
Community Sentiment
Key Developments & Data
Neko Health and Neuralink reportedly collaborate to pre-screen candidates for brain implant trials.
Neko Health raised $700 million in Series C funding on July 15, 2026, to expand its $499 full-body scan service into the US.
The process uses consented full-body scan data to filter potential candidates for Neuralink's PRIME Study targeting quadriplegia.
The companies haven't officially confirmed the partnership through traditional channels after details surfaced on social media.
Using retail body scanners to filter brain implant candidates shifts medical trial funneling from specialized neurology clinics directly to consumer health chains.
Zubiqo Strategic Assessment
Primary Impact
Clinical trial recruitment operations for neurotech developers and preventative health providers.
Strategic Shift
Transitioning clinical trial pre-screening from traditional neurology clinics to commercial preventative scanning hubs.
The Ripple Effect
Consumer health monitoring companies will increasingly package patient biological datasets into recruitment pipelines for clinical trials.
This intelligence assessment is generated by Zubiqo's AI for informational purposes only.
Intelligence Quality Rating
Grade this brief: Slide & release to submit rating, or tap a preset.
🔥High Impact75%
Slide & release to voteImmune to accidental scroll
Zubiqo Briefing
The daily signal, delivered every weekday.
A concise weekday briefing on AI, technology and business. Zero PR fluff.
Subscribe directly on Substack
Subscription completes on Substack • Free • 1-click unsubscribe anytime
✓ Free on Substack✓ Official Substack enrollment✓ 1-click unsubscribe
